Allogeneic stem cell
Showing 26 - 50 of >10,000
Multiple Myeloma Trial in Hamburg (allogeneic HSCT)
Completed
- Multiple Myeloma
- allogeneic HSCT
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 1, 2022
MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- IFN-γ (interferon gamma-1b) injection
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jan 5, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 10, 2023
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)
Not yet recruiting
- Multiple Myeloma
- Allogeneic Stem Cell Transplantation
- CARTemis-1
-
Santander, Cantabria, Spain
- +4 more
Aug 1, 2023
Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)
Not yet recruiting
- Stem Cell Transplantation
- Fludarabine
- +9 more
-
Houston, TexasM D Anderson Cancer Center
May 4, 2022
Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Low-field magnetic resonance imaging
- +3 more
-
Erlangen, Bavaria, GermanyDepartment of Pediatrics and Adolescent Medicine
Oct 23, 2023
Opportunistic Fungal Infection, Opportunistic Viral Infection, Bone Marrow Transplant Infection Trial in Patra, Thessaloníki
Recruiting
- Opportunistic Fungal Infection
- +2 more
- Pentavalent-specific T cells (penta-STs)
-
Patra, Greece
- +1 more
Jul 26, 2022
CIBMTR Research Database
Recruiting
- Autologous Stem Cell Transplantation
- +6 more
-
Minneapolis, Minnesota
- +1 more
Jan 20, 2023
Bronchiolitis Obliterans Trial in Bordeaux (lung MRI)
Recruiting
- Bronchiolitis Obliterans
- lung MRI
-
Bordeaux, FranceCHU Bordeaux
Apr 11, 2022
Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan
Recruiting
- Acute Myeloid Leukemia, Adult
- +2 more
- Fludarabine and Busulfan
- Fludarabine and Melphalan
-
Wuhan, Hubei, ChinaWuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023
HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)
Withdrawn
- HIV Infection
- Analytical Treatment Interruption + bNAbs infusion
-
Milan, Lombardy, Italy
- +3 more
Aug 2, 2022
Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)
Completed
- Steroid Refractory GVHD
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Dec 15, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA Trial (Ruxolitinib 5 MG BID Oral Tablet)
Not yet recruiting
- The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
- Ruxolitinib 5 MG BID Oral Tablet
- (no location specified)
Jun 13, 2023
Allogeneic Stem Cell Transplantation Trial in Cincinnati (Xylitol, Placebo)
Not yet recruiting
- Allogeneic Stem Cell Transplantation
- Xylitol
- Placebo
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 28, 2022
Infectious and Noninfectious Lung Diseases Following Allogeneic
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)
Recruiting
- Hypomethylating Agent
- +2 more
- Venetoclax
- Azacitidine or decitabine
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023
Viral Infections After HSCT Trial in Washington (VSTs)
Active, not recruiting
- Viral Infections After HSCT
- VSTs
-
Washington, District of ColumbiaChildrens National Medical Center
Aug 30, 2022
Hematologic Diseases, Stem Cell Transplantation Trial in Besançon, Nancy (Blood sample)
Recruiting
- Hematologic Diseases
- Stem Cell Transplantation
- Blood sample
-
Besançon, France
- +1 more
Apr 5, 2022
Hodgkin Lymphoma, Lymphoid Leukemia, Multiple Myeloma Trial in Richmond (Intravenous (IV) and oral Vitamin C)
Active, not recruiting
- Hodgkin Lymphoma
- +6 more
- Intravenous (IV) and oral Vitamin C
-
Richmond, VirginiaVirginia Commonwealth University/ Massey Cancer Center
Mar 2, 2022
Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Neoplasm
- Magrolimab
- +2 more
- (no location specified)
Apr 24, 2023
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Baltimore, Boston, Columbus (Enasidenib)
Active, not recruiting
- Acute Myeloid Leukemia
- Chronic Myelomonocytic Leukemia
-
Baltimore, Maryland
- +3 more
Aug 8, 2022
Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland
Not yet recruiting
- Allogeneic Stem Cell Transplant Candidate
- +4 more
- Cellular therapy product
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 1, 2022
Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,
Recruiting
- Cutaneous T-cell Lymphoma
- +4 more
- Romidepsin
- +4 more
-
Columbus, OhioThe Ohio State University Cancer Center
Apr 18, 2022